The European Commission has confirmed a €3.7m investment for a new programme in physics and biomedicine.
14 scientists are set to study healthy ageing under the microscope. They will be developing new optical procedures to study the liver with high-resolution microscopy. The aim is to find out how medical drugs affect the liver and how the organ changes with ageing. The project DeLIVER, co-ordinated by Bielefeld University, Germany, will start in January 2018.
The scientists will be carrying out research for their doctorates at six European partner universities and at companies in a total of nine countries.
Dr Thomas Huser from Bielefeld University’s Faculty of Physics, said: “In the new project, researchers from physics and biomedicine are co-ordinating their analyses and their advances and jointly addressing healthy ageing – one of the greatest challenges to society today. It is the close link between the two disciplines that makes this programme special.”
Huser’s research group ‘Biomolecular Photonics’ is developing high-resolution microscopes that can make structures in body cells visible and accessible to research that traditional optical microscopes are unable to show.
He added: “DeLIVER offers young doctoral students an opportunity to work together with experienced scientists and to use advanced technology and the most modern methods in physics.
“This prepares them specifically for both the academic and non-academic labour market.”
This is now the seventh Marie Skłodowska-Curie Action (MSCA) at Bielefeld University.